IISc-incubated Mynvax to get funding to bring “warm” Covid vaccine to market

The company was developing novel recombinant vaccines for COVID-19 and human influenza and would use the proceeds to further clinical development for the same

from The Hindu - Business https://ift.tt/3rjH2qk
via IFTTT